`
`Applicant: VISUS THERAPEUTICS, INC.
`
`Application No.: 18/250,921
`
`§ 371(c) Date: April 27, 2023
`
`Confirmation No.: 4791
`
`Art Unit: 1613
`
`Examiner: HUANG,Gigi Georgiana
`
`Atty. Docket: 4902.0110003
`
`IN THE UNITED STATES PATENT AND TRADEMARKOFFICE
`
`
`
`Title: DEGRADANT COMPOUND AND COMPOSITIONS THEREOF(as amended)
`
`Reply to Unity of Invention Requirement and Preliminary Amendment
`
`Commissioner for Patents
`PO Box 1450
`Alexandria, VA 22313-1450
`
`Commissioner:
`
`Mail Stop Amendment
`
`In reply to the Office Action dated August 2, 2024, requesting an election of one group of
`
`claims to prosecute in the above-referenced patent application, Applicant submits the following
`
`amendment and remarks.
`
`Amendmentsto the Specification begin on page 2 of this paper.
`
`Amendments to the Claimsare reflected in the listing of claims, which begin on page 3 of
`
`this paper.
`
`Remarks and Arguments begin on page 5 of this paper.
`
`It is not believed that extensions of time are required beyond those that may otherwise be
`
`provided for in documents accompanying this paper. However, if additional extensions of time are
`
`necessary to prevent abandonmentof this application, then such extensions of time are hereby
`
`petitioned under 37 C.F.R. § 1.136(a), and any additional fees required to continue prosecution or
`
`appealof this application (including issue fee, fees for net addition of claims, or forwarding to
`
`appeal) are hereby authorized to be charged to our Deposit Account No. 19-0036.
`
`